MAIA Biotechnology, Inc.
- Last sale
- Nov 12, 2026 · -0.97%
- Market cap
- $62.99M
- 61.75M shares
- Filings
- 504
FY 2024
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
—
—
—Q3 2026N/M FY25 yoy
Q3 2026
- $62.99M
- —
- —
- 4.3×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $0 | reported |
Pharmaceutical preparations
MAIA Biotechnology, Inc. is the 318th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
FBIOFortress Biotech, Inc.$63.3M9.7%10.8%$66.3MCINGCingulate Inc.———$65.3MLFVNLifevantage Corp$182.6M20.1%2.8%$64.0MRNTXRein Therapeutics, Inc.$0.0——$63.1MHRTXHeron Therapeutics, Inc.$154.9M7.4%13.0%$63.1M
MAIAMAIA Biotechnology, Inc. (this company)———$63.0M
TNXPTonix Pharmaceuticals Holding Corp.$13.1M29.8%946.2%$62.6MACRVAcrivon Therapeutics, Inc.———$61.9MXBITXBiotech Inc.———$60.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
MAIA Biotechnology, Inc. · CIK 1878313 · Engraved from SEC EDGAR